Moffitt Cancer Center in Tampa is participating in a Phase 3 clinical trial of a personalized mRNA vaccine for melanoma. Doctors create the treatment from mutations found in a patient’s tumor after surgery, aiming to help prevent the cancer from returning.
WHO:Moffitt Cancer Center doctors and patients enrolled in the Phase 3 trial
WHAT:A personalized mRNA vaccine immunotherapy for melanoma, built from each patient’s tumor mutations after surgery
WHEN:Reported Aug 26, 2026 at 5:19 PM ET
WHERE:Tampa, Florida
WHY:The trial is based on using mutations unique to a patient’s tumor to create an individualized immunotherapy designed to help prevent melanoma from returning.
Reporting from 1 identified publisher for this event.
